Clinical Trials Browser

Recruiting × Nasopharyngeal Carcinoma × Chemotherapy, Adjuvant × Clear all

NCT07067268 2025-07-16

Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy

Phase 2 Recruiting

Nasopharyngeal Carcinoma